EuroQol five dimensions questionnaire (EQ-5D) utility values for each health state in the Markov model
| Utilities | PEA group | BPA group | PAH-targeted therapy group | No-treatment group |
| Pre-treatment | 0.504 [23]# | 0.504 [23]# | 0.504 [23]# | 0.504 [23]# |
| Post-treatment | 0.743 [23, 25]# | 0.705 [25]# | 0.73 [5] | 0.504¶ |
PES: pulmonary endarterectemy; PAH: pulmonary arterial hypertension. #: after transforming the known utility values derived from the SF-36 questionnaire to estimated EuroQol five dimensions (EQ-5D) values following the method reported by Rowen et al. [25]. ¶: identical to pre-treatment utility in PEA group.